🇫🇷 Genoway
ALGEN.PAFundamentals
Gross Margin
48.9%
Op. Margin
3.2%
Net Margin
4.4%
ROIC
1.8%
Rev Growth
-5.0%
Valuation
Price
2.48 EUR
Day
+0.00%
52-Week Range
2.10 - 3.20
Market Cap
31M EUR
Fwd P/E
16.5x
EV/EBITDA
-
Div Yield
-
Annual income statement #
Genoway annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 21.0m in 2025.
| Year | Revenue (EUR) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 21.0m | 669,358 | 928,000 | 4.4% |
| 2024 | 22.1m | 1.8m | 1.8m | 8.3% |
| 2023 | 20.0m | 2.1m | 1.6m | 7.8% |
| 2022 | 17.1m | 949,835 | 777,752 | 4.6% |
| 2021 | 14.0m | -4.6m | -322,598 | -2.3% |
| 2020 | 11.0m | -3.8m | -687,302 | -6.2% |
| 2019 | 14.3m | -575,135 | -1.0m | -7.3% |
| 2018 | 15.0m | 579,800 | 571,646 | 3.8% |
| 2017 | 13.2m | 753,776 | 1.9m | 14.7% |
| 2016 | 11.5m | 691,907 | 582,234 | 5.0% |
Financial Data #
Segment Breakdown #
Peers #
SPRINT.ST MAB.WA IVACC.ST VVY.AS PTG.WA MOC.WA ALCOX.PA SIGHT.PA BIOBV.HE CLBIO.ST ·
Compare in Screener
Dividends
Bubble
Events #
| Date | Type | Details | Price | Amount |
|---|